ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+12.73%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$225M
AUM Growth
+$225M
(-2.5%)
Cap. Flow
-$29.5M
Cap. Flow
% of AUM
-13.11%
Top 10 Holdings %
Top 10 Hldgs %
45.19%
Holding
92
New
27
Increased
21
Reduced
24
Closed
19
Top Buys
| 1 |
Sanofi
SNY
|
$5.95M |
| 2 |
WMGI
Wright Medical Group Inc
WMGI
|
$5.77M |
| 3 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
$4.85M |
| 4 |
Bristol-Myers Squibb
BMY
|
$4.84M |
| 5 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$4.75M |
Top Sells
| 1 |
Abbott
ABT
|
$13M |
| 2 |
Merck
MRK
|
$12.6M |
| 3 |
Johnson & Johnson
JNJ
|
$7.76M |
| 4 |
Universal Health Services
UHS
|
$7.16M |
| 5 |
AGN
Allergan plc
AGN
|
$6.96M |
Sector Composition
| 1 | Healthcare | 92.74% |
| 2 | Industrials | 2.11% |
| 3 | Financials | 2.08% |
| 4 | Technology | 0.89% |
| 5 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cigna
CI
$80.3B
| $17.2M | 7.67% | 82,814 +18,353 | +28% | +$3.82M |
|
|
SHPG
2
DELISTED
Shire pic
SHPG
| $16.3M | 7.27% | 90,143 +22,250 | +33% | +$4.03M |
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $15M | 6.65% | 78,520 -36,552 | -32% | -$6.96M |
|
|
TVTY
4
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $9.99M | 4.44% | 310,596 +150,904 | +94% | +$4.85M |
|
|
WMGI
5
DELISTED
Wright Medical Group Inc
WMGI
| $8.92M | 3.97% | 307,216 +198,958 | +184% | +$5.77M |
|
|
CELG
6
DELISTED
Celgene Corp
CELG
| $8.81M | 3.92% | 98,401 +27,196 | +38% | +$2.43M |
|
7
CVS Health
CVS
$92.8B
| $7.2M | 3.2% | 91,418 -15,655 | -15% | -$1.23M |
|
8
Medtronic
MDT
$119B
| $6.41M | 2.85% | 65,129 -59,595 | -48% | -$5.86M |
|
|
9
Sanofi
SNY
$121B
| $5.95M | 2.65% | +133,245 | New | +$5.95M |
|
|
10
Abbott
ABT
$231B
| $5.78M | 2.57% | 78,718 -177,089 | -69% | -$13M |
|
|
11
Merck
MRK
$210B
| $5.68M | 2.53% | 80,093 -177,980 | -69% | -$12.6M |
|
12
Baxter International
BAX
$12.7B
| $5.26M | 2.34% | 68,190 -12,039 | -15% | -$928K |
|
13
Zimmer Biomet
ZBH
$21B
| $5.2M | 2.31% | 39,564 +17,107 | +76% | +$2.25M |
|
14
DaVita
DVA
$9.85B
| $5.02M | 2.23% | 70,090 -68,586 | -49% | -$4.91M |
|
|
15
Bristol-Myers Squibb
BMY
$96B
| $4.84M | 2.15% | +77,971 | New | +$4.84M |
|
|
OXFD
16
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $4.79M | 2.13% | 295,229 +138,360 | +88% | +$2.25M |
|
17
Stryker
SYK
$150B
| $4.77M | 2.12% | 26,821 +17,461 | +187% | +$3.1M |
|
|
RCM
18
DELISTED
R1 RCM Inc. Common Stock
RCM
| $4.75M | 2.11% | +467,463 | New | +$4.75M |
|
|
AET
19
DELISTED
Aetna Inc
AET
| $4.67M | 2.08% | 23,017 -6,180 | -21% | -$1.25M |
|
20
Elevance Health
ELV
$71.8B
| $4.66M | 2.07% | 17,008 -19,928 | -54% | -$5.46M |
|
21
Bausch Health
BHC
$2.74B
| $4.22M | 1.88% | 164,441 +117,512 | +250% | +$3.02M |
|
22
Standard BioTools
LAB
$481M
| $4.21M | 1.87% | 562,584 +448,474 | +393% | +$3.36M |
|
23
Pfizer
PFE
$141B
| $4.07M | 1.81% | 92,390 +58,238 | +171% | +$2.57M |
|
24
Viatris
VTRS
$12.3B
| $3.95M | 1.75% | 107,778 -71,497 | -40% | -$2.62M |
|
25
Hologic
HOLX
$14.9B
| $3.81M | 1.7% | 93,045 +9,389 | +11% | +$385K |
|